235 related articles for article (PubMed ID: 36802585)
1. P1 Bacteriophage-Enabled Delivery of CRISPR-Cas9 Antimicrobial Activity Against
Huan YW; Torraca V; Brown R; Fa-Arun J; Miles SL; Oyarzún DA; Mostowy S; Wang B
ACS Synth Biol; 2023 Mar; 12(3):709-721. PubMed ID: 36802585
[TBL] [Abstract][Full Text] [Related]
2. The Role of O-antigen in P1 Transduction of Shigella flexneri and Escherichia coli with its Alternative S' Tail Fibre.
Huan YW; Fa-Arun J; Wang B
J Mol Biol; 2022 Nov; 434(21):167829. PubMed ID: 36116540
[TBL] [Abstract][Full Text] [Related]
3. Non-replicative phage particles delivering CRISPR-Cas9 to target major blaCTX-M variants.
Nittayasut N; Yata T; Chirakul S; Techakriengkrai N; Chanchaithong P
PLoS One; 2024; 19(5):e0303555. PubMed ID: 38753729
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas-Guided Mutagenesis of Chromosome and Virulence Plasmid in Shigella flexneri by Cytosine Base Editing.
Sharma A; Omer Aden R; Puhar A; Cisneros DA
mSystems; 2023 Feb; 8(1):e0104522. PubMed ID: 36541764
[TBL] [Abstract][Full Text] [Related]
5. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
Shen J; Zhou J; Chen GQ; Xiu ZL
J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
[No Abstract] [Full Text] [Related]
6. High-Throughput CRISPR Screens To Dissect Macrophage-
Lai Y; Cui L; Babunovic GH; Fortune SM; Doench JG; Lu TK
mBio; 2021 Dec; 12(6):e0215821. PubMed ID: 34933448
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR/Cas9-Based Genome-Editing to Combat This Health Emergency.
Allemailem KS
Int J Nanomedicine; 2024; 19():1125-1143. PubMed ID: 38344439
[TBL] [Abstract][Full Text] [Related]
8. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
9. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
10. Development of a P1 phagemid system for the delivery of DNA into Gram-negative bacteria.
Westwater C; Schofield DA; Schmidt MG; Norris JS; Dolan JW
Microbiology (Reading); 2002 Apr; 148(Pt 4):943-950. PubMed ID: 11932441
[TBL] [Abstract][Full Text] [Related]
11. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9 Based Bacteriophage Genome Editing.
Zhang X; Zhang C; Liang C; Li B; Meng F; Ai Y
Microbiol Spectr; 2022 Aug; 10(4):e0082022. PubMed ID: 35880867
[TBL] [Abstract][Full Text] [Related]
13. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.
Wang Y; Tang Y; Zhao XM; Huang G; Gong JH; Yang SD; Li H; Wan WJ; Jia CH; Chen G; Zhang XN
Acta Biomater; 2022 Nov; 153():481-493. PubMed ID: 36162766
[TBL] [Abstract][Full Text] [Related]
14. Doc-mediated cell killing in Shigella flexneri using a C1/LacI controlled expression system.
Schofield DA; Westwater C; Dolan JW; Norris JS; Schmidt MG
FEMS Microbiol Lett; 2002 Oct; 215(2):237-42. PubMed ID: 12399040
[TBL] [Abstract][Full Text] [Related]
15. Different Methods of Delivering CRISPR/Cas9 Into Cells.
Chandrasekaran AP; Song M; Kim KS; Ramakrishna S
Prog Mol Biol Transl Sci; 2018; 159():157-176. PubMed ID: 30340786
[TBL] [Abstract][Full Text] [Related]
16. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
17. Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus.
Park JY; Moon BY; Park JW; Thornton JA; Park YH; Seo KS
Sci Rep; 2017 Mar; 7():44929. PubMed ID: 28322317
[TBL] [Abstract][Full Text] [Related]
18. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
Zhang Y; Huang H; Zhang B; Lin S
Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
[TBL] [Abstract][Full Text] [Related]
19. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System.
Bian WP; Chen YL; Luo JJ; Wang C; Xie SL; Pei DS
ACS Synth Biol; 2019 Apr; 8(4):621-632. PubMed ID: 30955321
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 in genome editing: Its function and medical applications.
Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
